Gamma-glutamyltransferase level in pregnancy is an independent risk factor for gestational diabetes mellitus
- 1 August 2008
- journal article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 34 (4), 512-517
- https://doi.org/10.1111/j.1447-0756.2008.00815.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory clinical indicators of hyperemesis severityJournal of Obstetrics and Gynaecology Research, 2007
- Screening for gestational diabetes at antenatal booking in a Malaysian university hospital: The role of risk factors and threshold value for the 50-g glucose challenge testAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Targeting postprandial hyperglycemiaMetabolism, 2006
- Readmission risk and metabolic, biochemical, haematological and clinical indicators of severity in hyperemesis gravidarumAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Serum γ‐glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general populationJournal of Internal Medicine, 2005
- Screening for gestational diabetes mellitusSeminars in Fetal and Neonatal Medicine, 2005
- γ-Glutamyltransferase, Obesity, and the Risk of Type 2 Diabetes: Observational Cohort Study among 20,158 Middle-Aged Men and WomenJournal of Clinical Endocrinology & Metabolism, 2004
- γ-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) StudyClinical Chemistry, 2003
- Gamma-glutamyltransferase and diabetes—a 4 year follow-up studyDiabetologia, 2003
- Gestational Diabetes and the Incidence of Type 2 DiabetesDiabetes Care, 2002